Chronic idiopathic intestinal pseudo-obstruction: The need for a multidisciplinary approach to management

Proceedings of the Nutrition Society

Volumn 63, Issue 3, 2004, Pages 473-480

  Silk, David B A ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Chronic idiopathic intestinal pseudo obstruction; Irritable bowel syndrome; Multidisciplinary management model; Nutritional management plan; Symptom based classification

Indexed keywords

ALPHA ACTIN; EPITOPE;

ABDOMINAL PAIN; CHRONIC DISEASE; COLON BIOPSY; COMORBIDITY; CONFERENCE PAPER; DIARRHEA; HUMAN; IDIOPATHIC DISEASE; INTESTINE BIOPSY; INTESTINE FUNCTION DISORDER; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE PSEUDOOBSTRUCTION; IRRITABLE COLON; LAPAROSCOPY; MANOMETRY; MENTAL DISEASE; MIDGUT DYSMOTILITY; MYALGIA; MYOPATHY; NEUROPATHY; NUTRITIONAL SUPPORT; OUTPATIENT; SYMPTOMATOLOGY; URINARY TRACT DISEASE;

CHRONIC DISEASE; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; IRRITABLE BOWEL SYNDROME; NUTRITIONAL SUPPORT; PAIN; PATIENT CARE TEAM;

EID: 4344672480     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2004375     Document Type: Conference Paper

References (55)

1. Accarino AM, Azpiroz F & Malagelada J (1995) Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 108, 636-643.
2. Bowling TE, Raimundo AH, Grimble GK & Silk DB (1993) Reversal of short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet 342, 1266-1268.
3. Camilleri M, Brown ML & Malagelada JR (1986) Impaired transit of chime in chronic intestinal pseudoobstruction: correction by cisapride. Gastroenterology 91, 619-626.
4. Camilleri M & Choi M-G (1997) Review article: irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 11, 3-15.
5. Camilleri M, Haslam WL, Parkman HP, Quigley EM & Soffer E (1998) Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 115, 747-762.
6. Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V & Zinsmeister AR (1989) Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudo-obstruction. Gastroenterology 96, 704-712.
7. Camilleri M & Prather CM (1992) The irritable bowel syndrome: mechanisms and a practical approach to management. Annals of Internal Medicine 116, 1001-1008.
8. Castle MZD, Silk DBA & Libby GW (2004) The rationale for antidepressant therapy in functional gastrointestinal disorders. Alimentary Pharmacology and Therapeutics 19, 1-11.
9. Cole SJ, Duncan HD, Claydon AH, Austin D, Bowling TJ & Silk DBA (2002) Distal colonic motor activity in four subgroups of patients with irritable bowel syndrome. Digestive Diseases and Sciences 47, 345-355.
10. Croft P, Rigby AS, Boswell R, Schollum J & Silman A (1993) The prevalence of chronic widespread pain in the general population. Journal of Rheumatology 20, 710-713.
11. Drossman DA (1999) The functional gastrointestinal disorders and the Rome II process. Gut 45, Suppl. 11, 111-115.
12. Dyer NH, Dawson AM, Smith BF & Todd IP (1969) Obstruction of bowel due to lesion in the myenteric plexus. British Medical Journal 1, 686-689.
13. Fukuda K, Strauss S, Hickie I, Sharpe M, Dobbins J & Komaroff A (1994) The chronic fatigue syndrome; a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine 121, 953-959.
14. Fukudo S, Nomura T & Hongo M (1998) Impact of corticotrophin releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 42, 845-849.
15. Gorard DA, Libby GW & Farthing MJ (1994) Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 8, 159-166.
16. Gorard DA, Libby GW & Farthing MJ (1995) Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhoea-predominant irritable bowel syndrome. Digestive Diseases and Sciences 40, 86-95.
17. Harvey RF, Salih SY & Read AE (1983) Organic and functional disorders in 2000 gastroenterology outpatients. Lancet i, 632-634.
18. Heaton KW (1984) Irritable bowel syndrome. In Textbook of Gastroenterology, pp. 867-875 [IAD Bouchier, RN Allen, JHF Hodgson and MRB Keighley, editors]. London: Bailiere Tindall.
19. Holdcroft A & Power I (2003) Management of pain. British Medical Journal 326, 635-639.
20. Kellow JE & Phillips SF (1987) Altered small bowel motility in the irritable bowel syndrome is correlated with symptoms. Gastroenterology 92, 1885-1893.
21. Knowles CH, Silk DBA, Darzi A, Feakins R, Raimundo AH, Veress B, Crompton T, Lindberg G & Martin JE (2004) Deranged smooth muscle alpha fetoprotein-actin: a biomarker of intestinal pseudo-obstruction: a controlled multinational case series. Gut (In the Press).
22. Kumar D & Wingate DL (1985) The irritable bowel syndrome: a paroxysmal motor disorder. Lancet ii, 973-977.
23. Lipton AB & Knauer CM (1977) Pseudo-obstruction of the bowel. Therapeutic trial of metoclopramide. American Journal of Digestive Diseases 22, 263-265.
24. Macfarlane GJ, Morris S, Hunt IM, Benjamin S, McBeth J, Papageorgiou AC & Silman AJ (1999) Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behaviour. Journal of Rheumatology 26, 413-419.
25. Mann SD, Debinski HS & Kamm MA (1997) Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut 41, 675-681.
26. Manning AP, Thompson WG, Heaton KW & Morris AF (1978) Towards a positive diagnosis of the irritable bowel syndrome. British Medical Journal ii, 653-654.
27. Moore SW, Schneider JW & Kaschula ROC (2002) Unusual variations of gastrointestinal smooth muscle abnormalities associated with chronic intestinal pseudo-obstruction. Pediatric Surgery International 18, 13-20.
28. Moriarty KJ & Dawson AM (1982) Functional abdominal pain: further evidence that the whole gut is involved. British Medical Journal 284, 1670-1672.
29. Perlemuter G, Chaussade S, Wechsler B, Cacoub P, Dapiogny M, Kahan A, Godeau P & Courturier D (1998) Chronic intestinal pseudo-obstruction in systemic lupus erythematosis. Gut 43, 117-122.
30. Quigley EM, Deprez PH, Helstrom P, Husebye E, Soffer EE, Stangh V, Summers RW, Wilmer A & Wingate DL (1997) Ambulatory intestinal manometry: a consensus report on its clinical role. Digestive Diseases and Sciences 42, 2395-2400.
31. Raimundo AH, Rogers J, Grimble G, Cahill E & Silk DBA (1988) Colonic inflow and small bowel motility during intraduodenal enteral nutrition. Gut 29, A1469-A1470.
32. Raimundo AH, Rogers J & Silk DB (1990) Is enteral feeding related diarrhoea initiated by an abnormal colonic response to intragastic diet infusion? Gut 31, A119.
33. Raimundo AH, Rogers J & Silk DBA (1996) Prolonged ambulatory small intestinal and colonic motility monitoring: potential in irritable bowel syndrome - first report of prolonged ambulatory oesophageal, small intestinal and colonic motility in the same patient. European Journal of Gastroenterology and Hepatology 8, 81-84.
34. Richards DM, Scott NA, Shaffer JL & Irving M (1997) Opiate and sedative dependence predicts a poor outcome for patients receiving home parenteral nutrition. Journal of Parenteral and Enteral Nutrition 21, 336-338.
35. Ruuska TH, Karikoski R, Smith VV & Milla PJ (2002) Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis. Gastroenterology 122, 1133-1139.
36. Schmidt T, Hackelsberger N, Widmer R, Meisel C, Pfeiffer A & Kaess H (1996) Ambulatory 24-hour jejunal motility in diarrhoea-predominant irritable bowel syndrome. Scandinavian Journal of Gasterenterology 31, 581-589.
37. Scott SM, Picon L, Knowles CH, Forquet F, Yazaki E, Williams NS, Lunniss PJ & Wingate DL (2003) Automated quantitative analysis of nocturnal jejunal motor activity identifies abnormalities in individuals and subgroups of patients with slow transit constipation. American Journal of Gastroenterology 98, 1123-1134.
38. Silk DB (1998) Patients' views on IBS. International Journal of Gastroenterology 3, 20-22.
39. Silk DBA (1995a) Clinical presentation of IBS. IBS Monitor 1, 4-6.
40. Silk DBA (1995b) A logical approach to IBS. IBS Monitor 2, 2-4.
41. Silk DBA (2001) Impact of irritable bowel syndrome on personal relationships and working practices. European Journal of Gastroenterology and Hepatology 13, 1327-1332.
42. Silk DBA (2003) Management of IBS: start of a new era? European Journal of Gastroenterology and Hepatology 15, 679-696.
43. Small PK, Loudon MA, Hau CM, Noor H & Campbell FC (1997) Large-scale ambulatory study of postprandial jejunal motility in irritable bowel syndrome. Scandinavian Journal of Gastroenterology 32, 39-47.
44. Smith VV, Lake BD, Kamm MA & Nicholls RJ (1992) Intestinal pseudo-obstruction with deficient smooth muscle alpha fetoprotein-actin. Histopathology 21, 535-542.
45. Spiller RC, Trotman IF, Adrian TE, Bloom SR, Misiewicz JJ & Silk DBA (1988) Further characterization of the 'ileal brake' reflex in man - Effect of ileal perfusion of partial digests of fat, protein and starch on jejunal motility and release of neurotension, enteroglucagen and peptide YY. Gut 29, 1042-1051.
46. Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ & Silk DBA (1984) The ileal brake - inhibition of jejunal motility after ileal fat infusion in man. Gut 25, 365-374.
47. Stanghellini V, Camilleri M & Malagelada JR (1987) Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 28, 5-12.
48. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ & Muller-Lissner S (1999) Functional bowel disorders and functional abdominal pain. Gut 45, 1143-1147.
49. Trotman IF & Price CC (1986) Bloated irritable bowel syndrome defined by dynamic 99mTc brain scan. Lancet ii, 364-366.
50. Verne GN, Eaker EY, Hardy E & Sninsky C (1995) Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudo-obstruction. Digestive Diseases and Sciences 40, 1892-1901.
51. Weber FH & McCullum RW (1992) Clinical approaches in irritable bowel syndrome. Lancet 340, 1447-1451.
52. Whorwell PJ, Lupton EW, Erduran D & Wilson K (1986a) Bladder smooth muscle dysfunction in patients with irritable bowel syndrome. Gut 27, 1014-1017.
53. Whorwell PJ, McCallum M, Greed FH & Roberts CT (1986b) Non colonic features of irritable bowel syndrome. Gut 27, 37-40.
54. Wingate D, Hongo M, Kellow J, Lindberg G & Smout A (2002) Disorders of gastrointestinal motility: towards a new classification. Journal of Gastroentrology and Hepatology 17, Suppl. S1-S14.
55. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DI et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 33, 160-172.